Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Y / Y Equity Change	13.75 %	-6.66 %	26.36 %	37.75 %	16.27 %
Y / Y Net Income Change	-	-	8.96 %	41.84 %	-13.63 %
Return On Equity	21.18 %	-	20.59 %	23.88 %	23.19 %

VRTX all Ratios >> Back to VRTX Management Effectiveness >> See Quarterly VRTX Return On Equity

You need to upgrade your Flash Player

Roe Comment

In (Dec 31 2025) ROE improved to 21.18 % compare to previous year, due to net income growth.

Financial Statements
Vertex Pharmaceuticals Inc's Equity	$ 18,666 Millions	Annual VRTX's Balance sheet
Vertex Pharmaceuticals Inc's Annual Income	$ 3,953 Millions	Annual VRTX's Income Statement
Where are VRTX's Income coming from?		Visit VRTX's Income by Segment

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.